James O. Armitage, University of Nebraska Medical Center, Dept. of Oncology and Hematology, Omaha, US
Franco Cavalli, Oncology Institute of Southern Switzerland, Ufficio Prof. Cavalli, Bellinzona, CH
Joseph M. Connors, University of British Columbia Cancer Agency, Lymphoma Tumor Group, Vancouver, CA
Martin Dreyling, Munich University Hospital, Medical Clinic III, Munich, DE
Andrés J. M. Ferreri, San Raffaele Scientific Institute, Unit of Lymphoid Malignancies, Milan, IT
Francesco Forconi, University Hospital Southampton, Lymphoma clinic, Southampton, UK
Bernhard Gerber, Oncology Institute of Southern Switzerland (IOSI), Haematology Dpt., Bellinzona, CH
Christian Gisselbrecht, St.Louis Hospital, Dept. of Haematology, Paris, FR
Manuela Hoechstetter, Klinikum Schwabing, Klinik für Hämatologie, Onkologie, Immunologie, Palliativmed, Munich, DE
Werner Kempf, Kempf und Pfaltz Practice, Histologische Diagnostik, Zurich, CH
Eva Kimby, Karolinska Institute, Dept. of Hematology, Stockholm, SE
Stefan Knop, University Clinic Würzburg, Haematology Department, Würzburg, DE
Ralf Küppers, University of Duisburg-Essen, Medical School, Institute of Cell Biology (Cancer Research), Essen, DE
Jessica Okosun, Cancer Research UK, Centre for Haemato-Oncology, London, UK
Davide Rossi, Oncology Institue of Southern Switzerland (IOSI), Division of Haematology, Bellinzona, CH
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, DE
Emanuele Zucca, Oncology Institute of Southern Switzerland (IOSI), Dept. of Medical Oncology, Bellinzona, CH